The mixed analyst ratings for Ascendis Pharma indicate that there is potential for the stock price to increase in the short term. The average price target of $131.92 is higher than the current price of $92.08, suggesting an upside potential. However, the decrease in the average price target from the previous average of $144.75 may indicate some uncertainty in the market.